Report
Debbie Wang
EUR 101.80 For Business Accounts Only

We Saw Few Surprises in Abbott's Second-Quarter Results

Abbott reported second-quarter results that generally met our expectations on the top and bottom lines. However, we've modestly raised our fair value estimate to $47 per share, after slight upward adjustments to our projections for growth in cardiac rhythm management, electrophysiology, and neuromodulation products over 2017-19 thanks to new product launches and underlying growth in demand. We think Abbott's narrow moat remains intact and its trend is stable. 
We were pleased to see continued st...
Underlying
Abbott Laboratories

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Debbie Wang

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch